Passa al contenuto
Merck
  • A lufenuron pre-treatment may enhance the effects of enilconazole or griseofulvin in feline dermatophytosis?

A lufenuron pre-treatment may enhance the effects of enilconazole or griseofulvin in feline dermatophytosis?

Journal of feline medicine and surgery (2008-08-08)
Francesca Mancianti, Sara Dabizzi, Simona Nardoni
ABSTRACT

The effectiveness of enilconazole (4 weekly rinses with a 0.2% solution) or griseofulvin (50mg/kg twice daily for 40 days) following a pre-treatment with oral lufenuron (100mg/kg by-weekly for 8 weeks) was tested on 25 (11+14) Microsporum canis infected cats. Control animals were treated with lufenuron, griseofulvin and enilconazole alone. At day 150 pre-treated animals were culturally negative and clinically cured. While lufenuron alone was found to be ineffective against M canis infection, an immunomodulatory effect of the drug can be suggested, as reported in literature. Its use could be reserved to long-lasting infections, unsuccessfully treated with conventional drugs. Further studies are required to clearly establish the possible adjuvant effect of this molecule when used prior to enilconazole or griseofulvin.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Supelco
Lufenuron, PESTANAL®, analytical standard
Lufenuron, European Pharmacopoeia (EP) Reference Standard
Lufenuron for peak identification, European Pharmacopoeia (EP) Reference Standard